The FDA is Taking a Big Risk on AI
CareTalk: Healthcare. Unfiltered.
00:00
Intro
This chapter explores the FDA's decision to implement generative AI to speed up scientific reviews, highlighting the benefits and risks of this technology in a cautious regulatory environment. It critically examines the implications of AI in healthcare and the need for careful consideration before rapid adoption.
Transcript
Play full episode
